Eli Lilly and Company (LLY)’s Foundayo Hits New Weight Loss Milestone among Menopause Ladies

Eli Lilly and Company (NYSE:LLY) is one of the best forever stocks to buy, according to analysts. On June 7, Eli Lilly and Company (NYSE:LLY) announced top-line results for Foundayo (orforglipron), the only oral GLP-1 that can be taken without food or water restrictions.

Eli Lilly and Company (LLY)’s Foundayo Hits New Weight Loss Milestone among Menopause Ladies

Stokkete/Shutterstock.com

Clinical trial results showed that women with obesity and who were overweight experienced significant weight loss at the average stage of menopause on taking the highest dose of Foundayo. The candidate drug was associated with significant weight reduction at 72 weeks across various menopausal stages.

In ATTAIN 1, women in premenopausal taking Foundayo lost up to 14.4% of weight, and those in post-menopause lost up to 14.1%. In ATTAIN-2, women taking Foundayo lost significant weight despite struggling with type 2 diabetes. The trial results affirm that Foundayo is an effective weight loss remedy in women at every stage of menopause. The positive clinical trial results are a welcome given that Menopause is a major yet often overlooked driver of weight gain.

Eli Lilly and Company (NYSE:LLY) is a global healthcare and pharmaceutical leader that discovers, develops, and manufactures innovative medicines. It is well known for its blockbuster treatments for diabetes (such as Mounjaro), chronic weight management (such as Zepbound), oncology, immunology, and neurodegeneration.

While we acknowledge the risk and potential of LLY as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than LLY and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 8 Most Profitable Crypto-Exposed Stocks to Buy Now and 10 Best Robinhood Stocks Under $20 to Buy Now.

Disclosure: None. Follow Insider Monkey on Google News.

1281292 - 11759070 - 1